| Literature DB >> 31457469 |
Eun Ho Kim1, Hyun Mo Lee1, Myoung Sun Jeong2, Ji Yeon Ryu3, Junseong Lee3, Bun Yeoul Lee1.
Abstract
Ethylene tetramerization catEntities:
Year: 2017 PMID: 31457469 PMCID: PMC6641062 DOI: 10.1021/acsomega.6b00506
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Scheme 1Active Species Proposed for Ethylene Tetramerization, and the CrIII Complexes Targeted in This Work
Scheme 2Synthetic Scheme for the Target Complexes
Figure 1Thermal ellipsoid plots (30% probability level) of [(CH3CN)4Ag]+[B(C6F5)4]− (a), [(THF)4CrCl2]+[B(C6F5)4]− (b), and (o-Me2NC6H4CH2)3Cr (c). Selected bond distances (Å) and angles (deg) are as follows: In (a), Ag–N(1), 2.311(4); Ag–N(2), 2.293(4); Ag–N(3), 2.247(3); Ag–N(4), 2.323(3); N(1)–Ag–N(2), 120.99(11); N(3)–Ag–N(4), 135.82(10); N(2)–Ag–N(3), 102.70(11); N(1)–Ag–N(3), 106.56(10); C–N(1)–Ag, 170.1(3); C–N(2)–Ag, 172.1(3); C–N(3)–Ag, 177.9(2); C–N(4)–Ag, 155.7(3); angle between the N(1)–Ag–N(2) and N(3)–Ag–N(4) planes, 85.04(6). In (b), Cr–O(1), 2.002(3); Cr–O(2), 2.004(3); Cr–Cl(1), 2.2978(10); Cl(1)–Cr–Cl(1)′, 180; O(1)–Cr–O(1)′, 180; O(2)–Cr–O(2)′, 180; Cl(1)–Cr–O(1), 90; Cl(1)–Cr–O(2), 90; O (1)–Cr–O(2), 90. In (c), Cr–N(1), 2.4006(15); Cr–N(2), 2.4177(15); Cr–N(3), 2.3847(15); Cr–C(1), 2.1096(18); Cr–C(10), 2.1186(18); Cr–C(19), 2.1173(18); C(1)–Cr–N(2), 168.03(6); C(19)–Cr–N(1), 167.95(6); C(10)–Cr–N(3), 166.72(6).
Figure 2Thermal ellipsoid plots (30% probability level) of [1-CrCl2(THF)2]+[B(C6F5)4]− (a) and [12-CrCl2]+[B(C6F5)4]− (b). Selected bond distances (Å) and angles (deg) are as follows. In (a), Cr–Cl(1), 2.2799(15); Cr–Cl(2), 2.2869(15); Cr–P(1), 2.4413(14); Cr–P(2), 2.4844(15); Cr–O(1), 2.027(3); Cr–O(2), 2.057(3); Cl(1)–Cr–Cl(2), 179.59(7); P(1)–Cr–P(2), 66.85(5); P(1)–N–P(2), 106.0(2). In (b), Cr–Cl(1), 2.287(2); Cr–Cl(2), 2.273(2); Cr–P(1), 2.485(2); Cr–P(2), 2.454(2); Cr–P(3), 2.477(2); Cr–P(4), 2.464(2); Cl(1)–Cr–Cl(2), 171.97(9); P(1)–Cr–P(2), 66.90(8); P(1)–N(1)–P(2), 105.6(4).
Ethylene Oligomerization Resultsa
| entry | solvent | catalyst | activator | activity (kg/g-Cr/h) | 1-C6 (wt %) | cy-C6 (wt %) | 1-C8 (wt %) | >C10 (wt %) | PE (wt %) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | C6H5Cl | [ | Me3Al | 155 | 41.6 | 2.4 | 43.7 | 9.4 | 2.2 |
| 2 | C6H5Cl | [ | Me3Al | 50 | 30.4 | 3.4 | 61.3 | 3.2 | 1.1 |
| 3 | C6H5Cl | [ | Et3Al | 74 | 30.7 | 2.2 | 47.2 | 8.2 | 11.7 |
| 4 | C6H5Cl | [ | iBu3Al | 126 | 31.3 | 2.5 | 45.8 | 9.7 | 10.6 |
| 5 | C6H5Cl | [ | iBu3Al (+Me3Al, 6.6%) | 288 | 44.3 | 2.4 | 40.1 | 12.2 | 0.7 |
| 6 | C6H5Cl | [ | Et3Al (1 h activation) | 224 | 44.3 | 2.3 | 40.6 | 11.4 | 1.3 |
| 7 | C6H5Cl | [ | iBu3Al (1 h activation) | 221 | 37.5 | 2.1 | 46.6 | 12.6 | 1.0 |
| 8 | C6H5Cl | MMAO | 203 | 44.9 | 2.2 | 39.6 | 11.3 | 1.2 | |
| 9 | C6H5Cl | [ | Me3Al | 140 | 50.2 | 2.1 | 37.3 | 8.7 | 1.6 |
| 10 | MeC6H11 | [ | Et3Al | 13 | 8.4 | 3.1 | 53.5 | 30.6 | 3.7 |
| 11 | MeC6H11 | [ | iBu3Al | 26 | 10.5 | 4.5 | 68.0 | 14.9 | 1.3 |
| 12 | MeC6H11 | [ | Et3Al | 77 | 13.6 | 4.9 | 71.3 | 8.2 | 1.4 |
| 13 | MeC6H11 | [ | iBu3Al | 84 | 14.3 | 4.7 | 70.3 | 9.4 | 1.0 |
| 14 | MeC6H11 | [ | iBu3Al | 89 (1.5 h) | 13.8 | 4.8 | 70.9 | 9.4 | 0.4 |
| 15 | MeC6H11 | [ | (iBu2Al)2O | 29 | 20.8 | 3.2 | 44.5 | 11.2 | 8.0 |
| 16 | MeC6H11 | MMAO | 163 | 7.9 | 4.6 | 72.7 | 13.1 | 1.3 | |
| 17 | MeC6H5 | [ | iBu3Al | 65 | 8.1 | 3.1 | 58.4 | 8.5 | 0.8 |
| 18 | C6H10 | [ | iBu3Al | 168 | 15.2 | 4.9 | 74.1 | 5.3 | 0.3 |
| 19 | C6H10 | [ | Et3Al | 168 | 14.2 | 4.9 | 71.7 | 7.5 | 0.1 |
| 20 | C6H10 | [ | Et3Al | 160 (1 h) | 14.2 | 4.9 | 71.6 | 8.0 | 0.3 |
| 21 | C6H10 | MMAO | 257 | 10.1 | 4.7 | 73.1 | 8.3 | 0.9 |
Oligomerization conditions: Cr complex: 1.5 μmol; Al/Cr: 300; solvent: 20 mL; temperature: 75 °C for entries 1–9, 45 °C for entries 10–21; ethylene: 30 bar for entries 1–9, 45 bar for entries 10–21, 30 min.
Modified MAO sourced from Akzo Nobel (MMAO-3A 7.0 Al wt % in heptane).
Figure 3Ethylene consumption vs time monitored by a mass-flow controller (MFC) in the tetramerization reaction performed in methylcyclohexane (a) or cyclohexene (b) using [2-CrCl2(CH3CN)2]+[B(C6F5)4]−/iBu3Al or Et3Al.
Figure 419F NMR spectra of [(CH3CN)4CrCl2]+[B(C6F5)4]− (a), [1-CrCl2(CH3CN)2]+[B(C6F5)4]− (b), [1-CrCl2(CH3CN)2]+[B(C6F5)4]−/iBu3Al (Al/Cr, 20) (c), and [Li]+[B(C6F5)4]−/iBu3Al (Al/Li, 20) (d).